Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Paula Bellenoit and American Bar Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Paula Bellenoit and American Bar Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#336 What Are the Risks of Serial Acquisitions? Empirical Evidence From the Dialysis Industry

38:57
 
Share
 

Manage episode 496942254 series 3001999
Content provided by Paula Bellenoit and American Bar Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Paula Bellenoit and American Bar Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

There is a growing interest in understanding the economics of serial acquisitions, particularly in the healthcare industries and markets, and whether such corporate strategies lead to changes in prices and quality causing antitrust concerns. What has been found in existing economic studies? Paul Eliason, Assistant Professor of Economics at Brigham Young University and co-author of a leading study on serial acquisitions focusing on the dialysis industry, discusses his observations and insights with Anora Wang and Derek Jackson. Listen to this episode to learn about the knowns and unknowns from the empirical evidence as well as implications for competition policy.

With special guest:

Dr. Paul Eliason, Assistant Professor of Economics, Brigham Young University

Related Links:

How Acquisitions Affect Firm Behavior and Performance: Evidence from the Dialysis Industry, Journal of Quarterly Economics

Hosted by:

Anora Wang, Arnold & Porter Kaye Scholer LLP and Derek Jackson, Cohen & Gresser LLP

  continue reading

351 episodes

Artwork
iconShare
 
Manage episode 496942254 series 3001999
Content provided by Paula Bellenoit and American Bar Association. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Paula Bellenoit and American Bar Association or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

There is a growing interest in understanding the economics of serial acquisitions, particularly in the healthcare industries and markets, and whether such corporate strategies lead to changes in prices and quality causing antitrust concerns. What has been found in existing economic studies? Paul Eliason, Assistant Professor of Economics at Brigham Young University and co-author of a leading study on serial acquisitions focusing on the dialysis industry, discusses his observations and insights with Anora Wang and Derek Jackson. Listen to this episode to learn about the knowns and unknowns from the empirical evidence as well as implications for competition policy.

With special guest:

Dr. Paul Eliason, Assistant Professor of Economics, Brigham Young University

Related Links:

How Acquisitions Affect Firm Behavior and Performance: Evidence from the Dialysis Industry, Journal of Quarterly Economics

Hosted by:

Anora Wang, Arnold & Porter Kaye Scholer LLP and Derek Jackson, Cohen & Gresser LLP

  continue reading

351 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play